Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Liu, Jing ^a,b   Wei, Xiao Long ^a,b   Huang, Wen He ^a   Chen, Chun Fa ^a,b   Bai, Jing Wen ^a,b   Zhang, Guo Jun ^a,b  

^a CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PHOSPHORYLATED PROTEIN AKT 1; PROTEIN KINASE B; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PHOSPHOPROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84871669139     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052675     Document Type: Article

References (23)

1. Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
2. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
3. Liu W, Asa SL, Fantus IG, Walfish PG, Ezzat S, (2002) Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and-independent pathways. Am J Pathol 160: 511-519.
4. Skaar JR, D'Angiolella V, Pagan JK, Pagano M, (2009) SnapShot: F Box Proteins II. Cell 137.
5. Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, et al. (2002) Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 62: 3819-3825.
6. Yang G, Ayala G, De Marzo A, Tian W, Frolov A, et al. (2002) Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res 8: 3419-3426.
7. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, et al. (2001) Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A 98: 5043-5048.
8. Abdou AG, Asaad NY, Abd El-Wahed MM, Samaka RM, Allah MS, (2012) The prognostic value of Skp2 expression in Egyptian diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol 20: 47-55.
9. Zheng WQ, Zheng JM, Ma R, Meng FF, Ni CR, (2005) Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy. Steroids 70: 770-774.
10. Traub F, Mengel M, Luck HJ, Kreipe HH, von Wasielewski R, (2006) Prognostic impact of Skp2 and p27 in human breast cancer. Breast Cancer Res Treat 99: 185-191.
11. Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, et al. (2009) Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol 11: 397-408.
12. Lin HK, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, et al. (2009) Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol 11: 420-432.
13. Genestie C, Zafrani B, Asselain B, Fourquet A, Rozan S, et al. (1998) Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res 18: 571-576.
14. Baba Y, Nosho K, Shima K, Hayashi M, Meyerhardt JA, et al. (2011) Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers. Cancer 117: 1399-1408.
15. Chen G, Cheng Y, Zhang Z, Martinka M, Li G, (2011) Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival. PLoS One 6: e17578.
16. Cardoso F, Saghatchian M, Thompson A, Rutgers E, (2008) Inconsistent criteria used in American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 26: 2058-2059; author reply 2060-2051.
17. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, et al. (2002) PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8: 1145-1152.
18. Chan CH, Li CF, Yang WL, Gao Y, Lee SW, et al. (2012) The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 149: 1098-1111.
19. Liu SG, Wang BS, Jiang YY, Zhang TT, Shi ZZ, et al. (2011) Atypical protein kinase Ciota (PKCiota) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCiota-SKP2-AKT pathway. Mol Cancer Res 9: 390-402.
20. Rodier G, Coulombe P, Tanguay PL, Boutonnet C, Meloche S, (2008) Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APC(Cdh1) in G1 phase. EMBO J 27: 679-691.
21. Ganiatsas S, Dow R, Thompson A, Schulman B, Germain D, (2001) A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT. Oncogene 20: 3641-3650.
22. Radke S, Pirkmaier A, Germain D, (2005) Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer. Oncogene 24: 3448-3458.
23. Chander H, Halpern M, Resnick-Silverman L, Manfredi JJ, Germain D, (2011) Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4. PLoS One 6: e22456.